NASDAQ:INO   Inovio Pharmaceuticals, Inc.
As a disclosure I am quite new to reading charts, but i have been learning. In this chart you can see that the consolidation of the highs and lows are funneling towards $13 a share. But keep in mind that a failing testing procedure can break the lows into a new support line. As the earnings are coming up, we may find a price rally.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。